U.S. Paper and Forestry Products Stock News

NYSE:TAP
NYSE:TAPBeverage

Why Molson Coors (TAP) Is Down 6.5% After Earnings Miss, Dividend Declaration And Analyst Downgrades

Molson Coors Beverage Company recently reported fourth-quarter 2025 results showing lower sales of US$3,125.8 million and net income of US$238.3 million, alongside a full-year net loss of US$2.14 billion, while also declaring a quarterly dividend of US$0.48 per share payable on March 20, 2026. At the same time, several analysts downgraded their views on Molson Coors following these results and its cautious outlook, highlighting pressure from declining beer volumes and cost headwinds even as...
NYSE:XPRO
NYSE:XPROEnergy Services

Expro Buyback And North Africa Contract Reframe Valuation And Cash Flow

Expro Group Holdings (NYSE:XPRO) has authorized a new $100 million share repurchase program. The company has secured a major multi-year contract in North Africa with an initial four-year term. Recent earnings included higher margins and free cash flow, alongside softer revenue in certain regions. Expro Group, a global energy services provider listed on the NYSE as XPRO, is active across well construction, well flow management, and subsea services. The mix of a sizable buyback authorization...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Is Churchill Downs (CHDN) Pricing Reflect Recent Share Weakness And Cash Flow Forecasts?

If you are wondering whether Churchill Downs at around US$96 per share offers good value today, this article will walk through what the current price might be implying about the business. The stock has had a mixed run recently, with a 6.0% gain over the last week, a 5.3% decline over the last 30 days, and returns of 14.1% decline year to date and 15.9% decline over the last year. The 3 year and 5 year returns are 20.9% decline and 16.6% decline respectively. Recent coverage around Churchill...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Margin Compression Reinforces Bearish Narrative Despite FY 2025 Revenue Strength

Corcept Therapeutics FY 2025 earnings snapshot Corcept Therapeutics (CORT) has wrapped up FY 2025 with Q4 revenue of US$202.1 million and basic EPS of US$0.24, alongside net income of US$25.4 million. Over the past six quarters, the company has seen revenue move from US$181.9 million in Q4 2024 to a range between US$157.2 million and US$207.6 million per quarter, while basic EPS has ranged between US$0.19 and US$0.45. With a trailing 12 month net profit margin of 13.1% compared to 20.7% a...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Is Coupang (CPNG) Pricing Reflect Its South Korean E Commerce Strength After Recent Share Pullback

If you are wondering whether Coupang's current share price really reflects what the business is worth, this article will walk through what the numbers are saying about value. The stock last closed at US$18.36, with returns of 1.7% over 7 days, a 6.2% decline over 30 days, a 21.4% decline year to date, and a 26.6% decline over 1 year. The 3 year return sits at 25.2%. Recent coverage has focused on Coupang's position in the South Korean e commerce market and how its scale and logistics network...
NYSE:FERG
NYSE:FERGTrade Distributors

Assessing Ferguson Enterprises (FERG) Valuation After A Year Of Strong Shareholder Returns

Event context and recent performance snapshot Ferguson Enterprises (FERG) has drawn investor attention after recent trading, with the share price closing at US$260.66 and month and past 3 months returns sitting in the low single digits. See our latest analysis for Ferguson Enterprises. While the recent 1-day share price return of 0.45% and 7-day share price return of 0.25% look quiet, Ferguson Enterprises has seen stronger momentum over longer horizons, with a 15.84% year to date share price...
NYSE:OMF
NYSE:OMFConsumer Finance

OneMain Holdings Gains Institutional Attention With Valuation Gap In Russell 1000

OneMain Holdings, Inc. (NYSE:OMF) is drawing increased attention for its role in consumer finance, and its presence in the Russell 1000 index reflects growing institutional interest. The company’s focus on personalized lending services is standing out against peers and reinforcing its position in the consumer finance segment. Recent stock data shows NYSE:OMF closed at $56.37, with a 1 year return of 14.6% and a 3 year return of 67.9%. For investors watching consumer lenders, OneMain...
NYSE:MCD
NYSE:MCDHospitality

McDonald's (MCD) Margin Steadiness Tested By Premium Valuation After FY 2025 Results

McDonald's (MCD) closed out FY 2025 with fourth quarter revenue of US$7.0 billion and basic EPS of US$3.03, alongside net income of US$2,164 million, setting the tone for a year where trailing 12 month revenue reached US$26.9 billion and EPS came in at US$12.00. Over the past few quarters, revenue has moved from US$5,956 million in Q1 2025 to US$7,078 million in Q3 2025 before landing at US$7,009 million in Q4. Quarterly EPS ranged between US$2.61 and just over US$3.19, with a trailing net...
NYSE:ASA
NYSE:ASACapital Markets

Is Saba’s Renewed Activism Pushing ASA (ASA) Toward a New Strategic Path for Shareholders?

On February 19, 2026, activist investor Saba Capital Management LP announced it had submitted an updated presentation urging ASA Gold and Precious Metals Limited’s Board to undertake a comprehensive strategic review, including clarified potential alternatives. This renewed activist push highlights how governance pressure at a specialized gold-miner-focused closed-end fund can influence expectations around its future direction and structure. Against this backdrop, we’ll examine how Saba...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Mixed Share Price Performance

Rhythm Pharmaceuticals overview Rhythm Pharmaceuticals (RYTM) has drawn investor attention after recent trading, with the stock last closing at US$99.15 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for Rhythm Pharmaceuticals. The recent 1-day share price return of 0.51% to US$99.15 sits against weaker 30 and 90 day share price returns, while the very large 5 year total shareholder return points to a stock that has already rewarded patient...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

Is Dropbox (DBX) Now Attractively Priced After Recent Share Price Weakness?

Wondering whether Dropbox is a bargain or just fairly priced at its current level? This article walks through what the numbers are saying about the stock's value. Dropbox shares last closed at US$24.43, with returns of a 1.2% decline over 7 days, 7.9% decline over 30 days, 9.3% decline year to date, 5.9% decline over 1 year, 18.2% over 3 years and 6.0% over 5 years, which may have some investors reassessing the balance between opportunity and risk. Recent coverage around Dropbox has focused...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Trinity Capital (TRIN) Net Margin Slippage Challenges Bullish Profitability Narratives

Trinity Capital (TRIN) closed out FY 2025 with Q4 total revenue of US$77.6 million and basic EPS of US$0.51, alongside trailing twelve month revenue of US$279.5 million and EPS of US$1.96, set against reported earnings growth of 17.3% over the past year. Over recent periods the company has seen revenue move from US$205.2 million on a trailing basis in Q3 2024 to US$226.7 million in Q4 2024 and then to US$279.5 million by Q4 2025. Trailing EPS shifted from US$1.79 to US$2.19 and then to...
NYSE:ABCB
NYSE:ABCBBanks

How Investors May Respond To Ameris Bancorp (ABCB) Leadership Refresh Following Retirement of Strategy Chief

Ameris Bancorp recently announced that Corporate Executive Vice President and Chief Strategy Officer James A. LaHaise will retire on April 30, 2026, with a three-month transition period and retirement benefits under an existing supplemental plan. His departure, alongside the earlier-disclosed retirement of Chief Risk Officer Bill McKendry and internal promotions to fill these roles, highlights an important refresh of Ameris’s leadership bench in strategy, risk, and oversight functions. We’ll...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Exelon PJM Transmission Win Puts Grid Reliability And Debt Trade Offs In Focus

Exelon (NasdaqGS:EXC) and NextEra Energy Transmission received approval from the PJM Board of Directors for a large multi state transmission line project. The project is intended to address electric grid reliability and affordability across a broad region. The new transmission capacity is expected to support future generation projects and help accommodate growing electricity demand. For investors watching utilities, this development sits at the intersection of grid reliability, cost...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

Has MACOM Technology Solutions (MTSI) Risen Too Far After Its 1-Year Share Price Surge?

If you are wondering whether MACOM Technology Solutions Holdings at around US$253.37 still offers value after a strong run, you are not alone. The stock has returned 2.7% over the last 7 days, 15.8% over 30 days, 44.8% year to date and 113.5% over 1 year, with a very large 3 year and 5 year return of 268.1% and 300.7% respectively. This naturally raises questions about what is already priced in. These moves have kept MACOM in focus as investors reassess where it fits within the wider...
NasdaqCM:ASPI
NasdaqCM:ASPIChemicals

Does ASP Isotopes’ (ASPI) CEO-Led Conference Spotlight Recast Its Management Credibility Narrative?

ASP Isotopes Inc. previously presented at the Emerging Growth Virtual Conference on February 25, 2026, with Executive Chairman and CEO Paul Elliot Mann outlining the company’s latest developments to a broad investor audience. The appearance gave investors a rare opportunity to hear directly from ASP Isotopes’ top leadership, potentially clarifying its progress and priorities within the specialized isotopes space. Next, we’ll consider how this direct CEO-led conference presentation may shape...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

What Neogen (NEOG)'s HYCOAT Recall for Contamination Concerns Means For Shareholders

In February 2026, Neogen Corporation announced a voluntary recall of all in-date lots of its Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution after microbial contamination was detected and adverse events were reported in horses, and the company is working with the FDA while its investigation continues. Management has emphasized that no adverse events have been linked to use strictly following the labeled directions, highlighting how product handling and administration practices may be...
NYSE:GPOR
NYSE:GPOROil and Gas

Gulfport Energy (GPOR) Profit Swing To US$396 Million Challenges Cautious Debt Narrative

Gulfport Energy (GPOR) has wrapped up FY 2025 with fourth quarter revenue of US$355.5 million and basic EPS of US$6.90, alongside net income excluding extra items of US$132.4 million. Over the past year, revenue on a trailing 12 month basis has moved from US$909.2 million in Q4 2024 to US$1.3 billion in Q4 2025, while basic EPS over the same window shifted from a loss of US$14.72 to a profit of US$21.74. This sets up a year in which margins and cash generation are front and center for...
NYSE:ALK
NYSE:ALKAirlines

Assessing Alaska Air Group (ALK) Valuation After Fleet Expansion Plans And Executive Share Sale

Executive share sale and major investment plans put Alaska Air Group (ALK) in focus Alaska Air Group (ALK) has drawn fresh attention after EVP and CCO Andrew R. Harrison sold 5,500 shares in an open market trade, alongside sizeable commitments to its fleet and airport infrastructure. See our latest analysis for Alaska Air Group. At a share price of $54.32, Alaska Air Group has seen a 27.78% 90 day share price return and 9.05% 30 day share price return. Its 1 year total shareholder return of a...
NYSE:HHH
NYSE:HHHReal Estate

Is It Time To Reassess Howard Hughes Holdings (HHH) After Prolonged Share Price Weakness

If you are wondering whether Howard Hughes Holdings is starting to look like value at today's price, or if the market still sees it as a work in progress, this article will walk you through what the numbers are really saying. Despite trading at US$72.77, the stock has seen recent pressure, with returns of a 12.4% decline over 7 days, a 10.2% decline over 30 days, a 7.7% decline year to date and a 1.8% decline over the past year, extending to a 7.5% decline over 3 years and an 18.4% decline...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics (UTHR) Net Margin Strength Reinforces Bullish Earnings Narrative

United Therapeutics (UTHR) FY 2025 Earnings Snapshot United Therapeutics (UTHR) closed FY 2025 with fourth quarter revenue of US$790.2 million and basic EPS of US$8.41, capping a twelve month run where trailing revenue reached US$3.2 billion and EPS came in at US$30.13. Over that period, revenue has moved from US$2.9 billion to US$3.2 billion and EPS has shifted from US$26.44 to US$30.13, giving investors a clear view of how the top line and EPS have tracked together. With a net income of...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

Is It Time To Reassess iRhythm Holdings (IRTC) After The Recent Share Price Pullback

If you are wondering whether iRhythm Holdings at around US$135.90 is still a sensible entry point or more of a hold, a closer look at its valuation can help frame that decision. The stock has pulled back recently, with a 7 day return of an 11.7% decline and a 30 day return of a 15.9% decline, although the 1 year return sits at 24.2% and the 3 year return at 15.0%. These moves sit against a backdrop of ongoing interest in digital cardiac monitoring and iRhythm's role in that space, which...
NasdaqGS:REYN
NasdaqGS:REYNHousehold Products

Reynolds Consumer Products (REYN) Valuation Check After Product Of The Year Recognition

Reynolds Consumer Products and the 2026 Product of the Year win Reynolds Consumer Products (REYN) is back on investors’ radar after its Reynolds Kitchens Parchment Cooking Bags were voted the 2026 Product of the Year in the Kitchen Essentials category, based on feedback from 40,000 American shoppers. See our latest analysis for Reynolds Consumer Products. The Product of the Year recognition comes after a mixed spell for Reynolds Consumer Products, with a 7 day share price return of 2.8% and a...
NasdaqGS:TLN
NasdaqGS:TLNRenewable Energy

A Look At Talen Energy (TLN) Valuation After Long Term AWS Deal And Reaffirmed 2026 Targets

Talen Energy (TLN) is back in focus after its long term deal to supply carbon free nuclear power to Amazon Web Services data centers, along with reaffirmed 2026 guidance and an ongoing share repurchase program. See our latest analysis for Talen Energy. The long term AWS contract, reaffirmed 2026 guidance and upcoming earnings update have arrived alongside a 1 month share price return of 11.71% and a 1 year total shareholder return of 79.79%. Together, these factors suggest momentum has...